These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32404341)

  • 1. Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão
    Joob B; Wiwanitkit V
    Ann Rheum Dis; 2021 Feb; 80(2):e24. PubMed ID: 32404341
    [No Abstract]   [Full Text] [Related]  

  • 2. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.
    Monti S; Montecucco C
    Ann Rheum Dis; 2020 Jun; 79(6):e62. PubMed ID: 32327429
    [No Abstract]   [Full Text] [Related]  

  • 3. No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit.
    Romão VC; Cruz-Machado AR; Fonseca JE
    Ann Rheum Dis; 2021 Feb; 80(2):e22. PubMed ID: 32404340
    [No Abstract]   [Full Text] [Related]  

  • 4. SLE patients are not immune to covid-19: importance of sending the right message across.
    Goyal M
    Ann Rheum Dis; 2021 Feb; 80(2):e23. PubMed ID: 32327426
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 May; 80(5):e72. PubMed ID: 32669304
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
    Horisberger A; Moi L; Ribi C; Comte D
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32376774
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 Feb; 80(2):e26. PubMed ID: 32451345
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19.
    Nasser N; Kurban M; Abbas O
    Rheumatol Int; 2021 May; 41(5):1019-1020. PubMed ID: 33666725
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort.
    Choi MY; Clarke AE; Buhler K; Jung M; Mathew H; Zhang M; Cardwell FS; Waldhauser H; Fritzler MJ
    Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35393285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are patients with systemic lupus erythematosus at increased risk for COVID-19?
    Favalli EG; Gerosa M; Murgo A; Caporali R
    Ann Rheum Dis; 2021 Feb; 80(2):e25. PubMed ID: 32451344
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 May; 80(5):e78. PubMed ID: 32759253
    [No Abstract]   [Full Text] [Related]  

  • 12. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection.
    Shayestehpour M; Zamani B
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11474. PubMed ID: 33275212
    [No Abstract]   [Full Text] [Related]  

  • 13. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection.
    Bonometti R; Sacchi MC; Stobbione P; Lauritano EC; Tamiazzo S; Marchegiani A; Novara E; Molinaro E; Benedetti I; Massone L; Bellora A; Boverio R
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9695-9697. PubMed ID: 33015814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie
    Gamboa-Alonso CM; Figueroa-Parra G; Galarza-Delgado DA
    Ann Rheum Dis; 2021 Jan; 80(1):e7. PubMed ID: 32571868
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev
    Spinelli FR; Ceccarelli F; Di Franco M; Conti F
    Ann Rheum Dis; 2021 Feb; 80(2):e20. PubMed ID: 32345618
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    Peschken CA
    J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of COVID-19 on hospitalization of patients with systemic lupus erythematosus (SLE).
    Lee WWH; Cheong YK; Teh CL; Wan SA; Chuah SL; Singh BSM
    Clin Rheumatol; 2021 Nov; 40(11):4775-4777. PubMed ID: 34510293
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini
    Monti S; Montecucco C
    Ann Rheum Dis; 2021 Feb; 80(2):e15. PubMed ID: 32414805
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on antimalarials and systemic lupus erythematosus.
    Ruiz-Irastorza G; Martín-Iglesias D; Soto-Peleteiro A
    Curr Opin Rheumatol; 2020 Nov; 32(6):572-582. PubMed ID: 32890029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.